A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition:   Cushing Syndrome Interventions:   Drug: ATR-101;   Drug: Placebos Sponsor:   Millendo Therapeutics, Inc. Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2017 Category: Research Source Type: clinical trials

A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition:   Cushing Syndrome Interventions:   Drug: ATR-101;   Drug: Placebos Sponsor:   Millendo Therapeutics, Inc. Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2017 Category: Research Source Type: clinical trials